Healthy volunteers needed for first human tests of new drug D-2570
NCT ID NCT07275775
First seen Dec 11, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This early-stage study tested the safety of a new drug called D-2570 in 100 healthy adults aged 18 to 45. Participants received either the drug or a placebo, and researchers measured how the drug moved through the body and checked for side effects. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shuguang Hospital
Shanghai, Shanghai Municipality, 200021, China
Conditions
Explore the condition pages connected to this study.